Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,004Revenue $M160Net Margin (%)-18.6Z-Score46.3
Enterprise Value $M2,953EPS $-0.4Operating Margin %-18.1F-Score6
P/E(ttm))0Cash Flow Per Share $-0.6Pre-tax Margin (%)-18.6Higher ROA y-yY
Price/Book33.410-y EBITDA Growth Rate %-21.7Quick Ratio2.9Cash flow > EarningsY
Price/Sales16.25-y EBITDA Growth Rate %-21.0Current Ratio3.2Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-24.3Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-35.4Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M74.9ROI % (ttm)-53.5Gross Margin Increase y-yY

Gurus Latest Trades with DXCM

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DXCMGeorge Soros 2013-09-30 Sold Out -0.02%$21.78 - $29.19
($25.33)
$ 39.8857%Sold Out0
DXCMGeorge Soros 2013-03-31 Buy 0.02%$13.59 - $17.05
($15.22)
$ 39.88162%New holding, 100000 sh.100,000
DXCMRon Baron 2012-12-31 Buy 0.11%$12.3 - $14.95
($13.39)
$ 39.88198%New holding, 1250000 sh.1,250,000
DXCMGeorge Soros 2011-09-30 Sold Out -0.0025%$10.3 - $15.66
($12.98)
$ 39.88207%Sold Out0
DXCMGeorge Soros 2011-06-30 Buy $13.05 - $16.72
($15.24)
$ 39.88162%New holding, 12500 sh.12,500
DXCMGeorge Soros 2011-03-31 Sold Out $13.3 - $15.79
($14.39)
$ 39.88177%Sold Out0
DXCMMario Gabelli 2011-03-31 Reduce-0.01%$13.3 - $15.79
($14.39)
$ 39.88177%Reduce -55.46%77,500
DXCMGeorge Soros 2010-09-30 Reduce$10.76 - $14.06
($12.31)
$ 39.88224%Reduce -43.37%14,100
DXCMGeorge Soros 2010-06-30 Buy 0.01%$9.22 - $11.65
($10.48)
$ 39.88280%New holding, 24900 sh.24,900
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DXCM is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
DXCM Ron Baron 2014-03-311,354,1121.810.23-0.24%
DXCM Mario Gabelli 2014-03-3171,0000.090.02-4.05%
Premium Most recent portfolio changes are included for Premium Members only!


DXCM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Balo Andrew KSVP, Regulatory and Clinical 2014-07-25Sell10,000$38.195view
Pacelli Steven RobertEVP, Strategy & Corp. Dev. 2014-07-23Sell14,000$38.284.75view
DOUBLEDAY RICHARDSr. VP. Worldwide Sales 2014-07-23Sell4,000$38.165.08view
ROPER JESSVP, CFO 2014-07-18Sell8,000$36.0111.36view
GREGG TERRANCE HCEO 2014-07-15Sell35,000$36.669.38view
LISTER JOHNSr. VP, General Counsel 2014-07-14Sell3,500$36.599.59view
Balo Andrew KSVP, Regulatory and Clinical 2014-07-11Sell10,000$35.9311.61view
VALDES JORGE ACTO 2014-07-08Sell16,000$36.669.38view
SKYLER JAY SDirector 2014-07-02Sell30,000$40.050.12view
Balo Andrew KSVP, Regulatory and Clinical 2014-06-25Sell10,000$40.6-1.23view

Press Releases about DXCM :

    Quarterly/Annual Reports about DXCM:

    News about DXCM:

    Articles On GuruFocus.com
    DexCom Reports $1 Million Insider Buy Mar 12 2013 
    DexCom Inc. Reports Operating Results (10-Q) Aug 03 2010 
    DexCom Inc. Reports Operating Results (10-Q) May 05 2010 
    DexCom Inc. Reports Operating Results (10-Q) Nov 04 2009 
    DexCom Inc. Reports Operating Results (10-Q) Aug 03 2009 
    DexCom Inc. Reports Second Quarter 2009 Financial Results Aug 03 2009 
    DexCom Inc. (DXCM) CEO Terrance H Gregg buys 20,000 Shares May 14 2009 
    DexCom Inc. Reports Operating Results (10-Q) May 06 2009 
    DexCom Inc. (DXCM) CEO Terrance H Gregg buys 50,000 Shares Mar 17 2009 
    DexCom Inc. (DXCM) CEO Terrance H Gregg buys 20,800 Shares Mar 13 2009 

    More From Other Websites
    DexCom Schedules Second Quarter 2014 Earnings Release and Conference Call for August 6, 2014 at 4:30... Jul 23 2014
    DexCom Schedules Second Quarter 2014 Earnings Release and Conference Call for August 6, 2014 at 4:30... Jul 23 2014
    5 New Medical Technologies For Diabetics Jul 18 2014
    DEXCOM INC Files SEC form 8-K, Entry into a Material Definitive Agreement Jul 07 2014
    DexCom Collaborates with Insulet Corporation Jun 16 2014
    Freedom for Diabetics as Bionic Pancreas Passes Testing Jun 15 2014
    Diabetics Get Freedom in Bionic Pancreas Real-World Trial Jun 15 2014
    DexCom’s Forthcoming Mobile App Platform to Integrate Data from Insulet’s OmniPod System Jun 13 2014
    Top Swing Trade Ideas for Thursday, June 5: DexCom, Conn's and More Jun 05 2014
    [video] Health app space heats up Jun 04 2014
    FDA Nod for DexCom's G4 PLATINUM System Jun 04 2014
    DEXCOM INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 04 2014
    The first and only real-time professional CGM, the Dexcom G4® PLATINUM Professional Continuous... Jun 03 2014
    DexCom Announces Upcoming Conference Presentations May 27 2014
    Why Jim Cramer Says Investors Should Watch DexCom (DXCM) Stock May 16 2014
    [video] Jim Cramer on Why DexCom Could be a Good Portfolio Addition May 16 2014
    The Bellwether We've Searched For May 16 2014
    DexCom has a conference call hosted by JPMorgan May 12 2014
    DEXCOM INC Financials May 09 2014
    DexCom Misses, Sees Broader Q1 Loss May 06 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide